SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats - Test2 - elhamkhani - TriplyDB

SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats

SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats

http://www.wikidata.org/entity/Q33856044

about

Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse A role for brain stress systems in addiction.The role of biogenic amine signaling in the bed nucleus of the stria terminals in alcohol abuse.Drug withdrawal conceptualized as a stressor.Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.An Update on CRF Mechanisms Underlying Alcohol Use Disorders and Dependence Importance of cocaine- and amphetamine-regulated transcript peptide in the central nucleus of amygdala in anxiogenic responses induced by ethanol withdrawal A controlled trial of flumazenil and gabapentin for initial treatment of methylamphetamine dependence Disruption of social approach by MK-801, amphetamine, and fluoxetine in adolescent C57BL/6J mice.Preclinical studies of alcohol binge drinking The Interplay between the Hippocampus and Amygdala in Regulating Aberrant Hippocampal Neurogenesis during Protracted Abstinence from Alcohol Dependence.Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20% ethanol.Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.Progress in corticotropin-releasing factor-1 antagonist development.The role of CRF and CRF-related peptides in the dark side of addiction.Conceptual framework for the etiology of alcoholism: a "kindling"/stress hypothesis.Interactions of stress and CRF in ethanol-withdrawal induced anxiety in adolescent and adult rats Differential dietary ethanol intake and blood ethanol levels in adolescent and adult rats: effects on anxiety-like behavior and seizure thresholds.Antagonism of the ethanol-like discriminative stimulus effects of ethanol, pentobarbital, and midazolam in cynomolgus monkeys reveals involvement of specific GABA(A) receptor subtypes.The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.Sensitization, duration, and pharmacological blockade of anxiety-like behavior following repeated ethanol withdrawal in adolescent and adult rats Revisiting intragastric ethanol intubation as a dependence induction method for studies of ethanol reward and motivation in rats.Modulation of ethanol withdrawal-induced anxiety-like behavior during later withdrawals by treatment of early withdrawals with benzodiazepine/gamma-aminobutyric acid ligands Pharmacological modulation of repeated ethanol withdrawal-induced anxiety-like behavior differs in alcohol-preferring P and Sprague-Dawley rats The amygdala regulates the antianxiety sensitization effect of flumazenil during repeated chronic ethanol or repeated stress.Similar anxiety-like responses in male and female rats exposed to repeated withdrawals from ethanol.Stress enhancement of craving during sobriety: a risk for relapse.Neurobiology of dysregulated motivational systems in drug addiction.Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues.How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective.Comparison of basal neuropeptide Y and corticotropin releasing factor levels between the high ethanol drinking C57BL/6J and low ethanol drinking DBA/2J inbred mouse strains.Corticotropin releasing factor: a key role in the neurobiology of addiction Functional alterations in the dorsal raphe nucleus following acute and chronic ethanol exposure.The dark side of emotion: the addiction perspective The role of progestins in the behavioral effects of cocaine and other drugs of abuse: human and animal research.Brain pathways to recovery from alcohol dependence The dark side of food addiction.

P2860

Q24633835-C1DFBF45-DB83-4852-9300-EC2A4819D580 Q24649537-157389CA-3073-4F86-8CD1-EF32D3E997FF Q26851494-4D2190BD-1DEC-4B88-89E5-F63F70F8A67C Q26997989-73BC6BA8-3601-4F2E-A629-DE1785F22712 Q27014879-69A36319-3EBC-4E08-81D1-C8522CEEEE51 Q28069782-1C660F8E-9E68-4B63-8A27-FC80142C3589 Q28236924-5AAE66B0-E9FD-44BE-8D28-57A098744515 Q28265814-2EFE2FF6-5C57-4CCE-86A7-83D0B7DCAEE8 Q28391513-83B17998-EAA8-4428-8D68-406375C8EA62 Q28741039-F17BE466-7843-41F9-A241-02FA8DDE94CF Q30452872-DBC377E3-B8F6-4279-A7C1-66666A9C0D49 Q30461402-9BA699CD-0D4D-49EA-B38A-651068566937 Q30466695-1B53E804-187D-42EF-AEC2-6FCF1870EBE0 Q30468942-19B46455-86C2-481D-8F89-7EA8C92B038A Q30475627-65F09206-0268-493A-A5B4-DCC919F7D154 Q30476985-41926B5A-1815-4990-BA72-4C089B788670 Q30479081-3A55B179-F2DB-4C74-843E-0CE5C6C3F8AF Q30479270-B52401BF-C374-456C-9AB4-1D34AB22F594 Q30481966-F4A2F052-B064-4E43-A51C-40B5F5A4F9DB Q30491170-E7ACB45D-54D7-478E-8F04-D8965FE20F55 Q33455500-4F483A86-1075-4D43-B9E3-3ED9B8752782 Q33616639-389227AF-CF52-459C-B2D9-F865C89FD554 Q33643476-ACD30F9C-B4EC-4A89-931C-DE9D77F22EF9 Q33760346-2139F6A9-2B3A-4ED5-A4E4-6CB93076DA67 Q33804938-98867554-C0AD-4216-84F3-E6F31AAEBEB0 Q33828072-8E973BE7-485E-4627-85FD-99CA399B5D15 Q33828125-632FFAE8-9BA3-4785-884C-ECE583C83654 Q33830101-48CD42CD-FC3C-40BA-839B-3CAD86FDA28B Q33835815-0879F238-D012-46BD-8CFF-7408CCDC85E7 Q33845663-F6718689-9AA5-4975-A0BF-EB4B588D82C5 Q33915824-693896C8-F778-4AA9-B44D-A0CCB44BA544 Q33940215-74BB268B-5B66-4738-9E3E-3608BF344732 Q34073903-2C0CDD2E-AFF9-45FA-8D71-3644CDC8A32B Q34333908-7BF79BF4-0C7C-4200-8E2D-E0ADE1E68602 Q34421204-6B26E5FB-0843-4EDA-A39A-1D2D8F5D992A Q34906736-FBAA99F5-EF1D-4C2C-A946-F1D4400F90C2 Q35235813-DC509EA8-F16F-4B57-9057-85E8CEF00116 Q35624709-AAF2562B-E118-4B33-BA11-EE31F60A6E6D Q35746391-00BEA6F8-196D-4629-B7C4-1A7D8416A180 Q35832522-BDFA487A-DE1C-4DE9-A67E-4F4D94AA1AED

P2860

SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats

http://www.wikidata.org/entity/Q33856044

description

2004 nî lūn-bûn

@nan

2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats

@ast

SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats

@en

type

label

SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats

@ast

SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats

@en

prefLabel

SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats

@ast

SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats

@en

P1433

Q33856044-94D0A273-5C80-42F3-9DB9-B25CA59004C3

P1476

Q33856044-9EEEC70A-D3C9-467E-B2E4-87ADC4EA960C

P2093

Q33856044-611D2F08-A96D-4367-B2AB-4325B1731CB5

Q33856044-64213523-3488-4CFB-8464-0979DCF95268

Q33856044-DA072091-8824-4AD3-BC91-93008A1FD5BE

Q33856044-F1F87A99-0C82-45E7-9757-462FA675E4C3

P2860

Q33856044-02B9EF87-56A3-481F-893E-16D76E45AD22

Q33856044-0CA0F908-8F1A-4A8B-B138-3DA4C847C82E

Q33856044-0CE18025-7C88-46D1-A80B-19B9C22AC88F

Q33856044-181E424A-016E-474D-8598-1CA91465CCEA

Q33856044-197866CA-7D36-43DF-9B4F-2AC737DCE84B

Q33856044-19F0CCEC-4412-4EAA-B30E-C5FD10D009DC

Q33856044-1DE7AB42-7668-42C3-AD4A-798A2D89A065

Q33856044-232587E6-A5E4-4A94-8E2E-D5B49A5E4EEC

Q33856044-26300560-9AE6-47BE-86FB-6D6F03A5A47B

Q33856044-34BA2FB4-6CD2-4AF2-8BA5-14C404AEDDB5

P304

Q33856044-A8E3936C-34FA-48B6-8361-80904056220C

P31

Q33856044-16E83C4C-9136-4946-AC97-AFC03EE8B310

P356

Q33856044-D9BD976E-5871-4267-B4A4-9DCB122A1D53

P433

Q33856044-D6CC5194-0E1D-4858-9D17-FCBF2D7359DA

P478

Q33856044-F4687D24-294F-475A-AF1C-AC56DE31D217

P577

Q33856044-FAB8BAD7-73F8-460F-B5FA-5A0476AFFF34

P5875

Q33856044-76D30E14-9059-42B1-A081-CF1C1B54CD5A

P698

Q33856044-EEDA798B-F889-4A64-A013-123F206B131F

P932

Q33856044-5F625A69-636A-4DDF-BD82-32EE379AD16E

P356

J.ALCOHOL.2003.08.007

P1433

P1476

SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats

@en

P2093

Darin J Knapp

http://www.w3.org/2001/XMLSchema#string

David H Overstreet

http://www.w3.org/2001/XMLSchema#string

George R Breese

http://www.w3.org/2001/XMLSchema#string

Sheryl S Moy

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties

International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function

Effects of nitrendipine, chlordiazepoxide, flumazenil and baclofen on the increased anxiety resulting from alcohol withdrawal

In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001

Drug abuse: hedonic homeostatic dysregulation

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals.

New insights into the mechanism of action of hypnotics.

Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.

Abecarnil and alprazolam reverse anxiety-like behaviors induced by ethanol withdrawal.

P304

101-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ALCOHOL.2003.08.007

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8542042

http://www.w3.org/2001/XMLSchema#string

P698

15163561

http://www.w3.org/2001/XMLSchema#string

P932

2871682

http://www.w3.org/2001/XMLSchema#string